Authors: Carlson, JA Amin, S Malfetano, J Tien, AT Selkin, B Hou, J Goncharuk, V Wilson, VL Rohwedder, A Ambros, R Ross, JS

Citation: Ja. Carlson et al., Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus, APPL IMMUNO, 9(2), 2001, pp. 150-163

Authors: Gore, M Huinink, WT Carmichael, J Gordon, A Davidson, N Coleman, R Spaczynski, M Heron, JF Bolis, G Malmstrom, H Malfetano, J Scarabelli, C Vennin, P Ross, G Fields, SZ

Citation: M. Gore et al., Clinical evidence for topotecan-paclitaxel non-cross-resistance in ovariancancer, J CL ONCOL, 19(7), 2000, pp. 1893-1900

Authors: Carlson, JA Grabowski, R Chichester, P Paunovich, E Malfetano, J

Citation: Ja. Carlson et al., Comparative immunophenotypic study of lichen sclerosus - Epidermotropic CD57+lymphocytes are numerous - Implications for pathogenesis, AM J DERMAT, 22(1), 2000, pp. 7-16

Authors: Carlson, JA Healy, K Tran, TA Malfetano, J Wilson, VL Rohwedder, A Ross, JS

Citation: Ja. Carlson et al., Chromosome 17 aneusomy detected by fluorescence in situ hybridization in vulvar squamous cell carcinomas and synchronous vulvar skin, AM J PATH, 157(3), 2000, pp. 973-983

Authors: Ross, G Malfetano, J Clarke-Pearson, D Oza, A Gore, M Beckman, R Fields, S Lane, S Dane, G

Citation: G. Ross et al., IV topotecan (TOPT) in patients (Pts) who relapse following platinum(P)/paclitaxel(TX) treatment: subset analysis of a phase III trial, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 285-289